Back to search

Ab Biotechnology Limited

08337863

active
Private Limited Company
england wales
Companies House
Health Score
90 / 100

Healthy

30/30
Filing
20/30
Financial
40/40
Risk

No risk factors detected.

Details

C/O BRODIES LLP, LONDON, EC1A 7BN
Incorporated 20/12/2012

Compliance

Last accounts

31/12/2025

small

Next accounts due

30/09/2027

On track

Confirmation statement

Last: 17/01/2026

Due 31/01/2027

On track

Industry

21100
Manufacture of basic pharmaceutical products
72110
Research and experimental development on biotechnology

Officers

Illia Pavlovskyi

director · Since 14/02/2017

NONE

UKRAINIAN · CYPRUS · Age 54

Serge Scotto

director · Since 14/02/2017

NONE

FRENCH · SWITZERLAND · Age 72

Persons with Significant Control

Irina Epshteyn

75–100% shares
75–100% votes

Maltese · Switzerland · Age 55

12c, Rue Guillaume J. Kroll, Luxembourg L - 1882

Notified 06/04/2016

CompanyRankvs 107+ SIC 21100 peers
81

Financial strength92th percentile among SIC peers · 23/25
Employees93th percentile among SIC peers · 14/15
LiquidityCurrent ratio 1.86× · 16/20
Longevity13 years trading (max 15) · 13/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength23/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees14/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity16/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity13/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/12/2025

Net Worth

£2.7M

Balance sheet strength

Cash

£1.6M

Cash in the bank

Net Current Assets

£1.4M

Working capital

Current Assets

£3.1M

Current Liabilities

£1.7M

Fixed Assets

£1.3M

Debtors

£1.3M

21avg. employees-1

Balance Sheet

Assets less current liabilities£2.7M
Prepared with CCH Software

EstimatesDerived

YearCurrent RatioImplied Profit
20251.86-£738k
20242.15+£21k
20233.34+£301k
20223.29

Derived from filed accounts. Not audited figures.